Related Experiment Video
Updated: Aug 9, 2026
05:49
Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
Published on: October 26, 2011
A new hepatoma cell line for toxicity testing at repeated doses
N Fabre1, E Arrivet, J Trancard
1Sanofi-Synthelabo Recherche, Department of Toxicology-Porcheville, Porcheville, France. nicolas.fabre@sanofi-synthelabo.com
Cell Biology and Toxicology
|June 5, 2003
Summary
A new human hepatoma cell line, HBG BC2, shows promise for repeated toxicity testing. This model better reflects chronic exposure toxicity compared to standard cell models.
Area of Science:
- Hepatology
- Toxicology
- Cell Biology
Background:
- Standard cytotoxicity cell models correlate well with acute toxicity but not chronic toxicity.
- The HBG BC2 human hepatoma cell line offers reversible differentiation and higher metabolic rates, suitable for repeated toxicity testing.
- Assessing chronic toxicity in vitro requires cell models that can mimic in vivo conditions more closely.
Purpose of the Study:
- To evaluate the HBG BC2 human hepatoma cell line for its utility in repeated toxicity testing.
- To assess the genetic stability and toxicological response of HBG BC2 cells under repeated exposure conditions.
- To compare the cytotoxicity of various compounds after single versus repeated administration in the HBG BC2 cell line.
Main Methods:
- Analysis of gene expression in untreated HBG BC2 cells to understand their genetic background.
- Repeated treatment of HBG BC2 cultures with acetaminophen to study cellular responses.
- Application of standard staining techniques and MTT reduction assay to quantify cytotoxicity.
- Evaluation of acetaminophen, acetylsalicylic acid, perhexiline, and propranolol toxicity after single and repeated dosing.
Main Results:
- HBG BC2 cells demonstrated the capacity for apoptosis and proliferation, indicating potential for cell replacement.
- Cytotoxicity was observed at lower doses of tested compounds under repeated administration compared to single administration.
- The lowest non-toxic doses in repeated exposure studies were comparable to therapeutic plasma concentrations in humans.
- The HBG BC2 cell line exhibited sensitivity to repeated drug exposure, reflecting chronic toxicity patterns.
Conclusions:
- The HBG BC2 human hepatoma cell line is a valuable tool for evaluating cell toxicity under repeated administration conditions.
- This cell line provides a more relevant model for predicting chronic toxicity than traditional acute cytotoxicity assays.
- HBG BC2 cells offer a promising in vitro platform for drug safety assessment, particularly for long-term exposure effects.
